Literature DB >> 18181835

Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.

Yasushi Iwasaki1, Maya Mimuro, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Gen Sobue.   

Abstract

We present five cases of dura mater-associated Creutzfeldt-Jakob disease (dura-CJD) that were analyzed clinicopathologically and review previous reports. The average age at dura mater transplantation was 54.4 +/- 7.3 years, and the average age at CJD onset was 66.0 +/- 8.2 years, with an average latency period of 11.6 +/- 1.1 years. The average age at death was 67.6 +/- 8.7 years, with an average CJD disease duration of 16.8 +/- 10.4 months. Symptoms of CJD onset in four patients who received dura mater transplantation below the cerebellar tent reflected cerebellar or brainstem dysfunction, whereas symptoms of one patient who received transplantation above the cerebellar tent reflected cerebral cortical involvement. All patients showed rapidly progressive cognitive impairment, and both periodic sharp-wave complexes on electroencephalogram and myoclonus were observed in the early disease stage. Neuropathologic evaluation showed one case of subacute spongiform encephalopathy and four cases of panencephalopathic-type CJD. Widespread cerebral neocortical, subcortical gray matter and cerebellar cortical involvement were observed to varying degrees, and severity tended to be associated with CJD disease duration. There were no instances of kuru plaques or florid plaques. Prion protein (PrP) immunostaining showed widespread synaptic-type PrP deposition. No differences between our dura-CJD cases and typical cases of sporadic CJD were found with respect to clinicopathologic findings, except history of dura mater transplantation. Although a specific association between the dura mater graft site and neuropathologic observations was not evaluated in the present study, the initial symptoms appear to be closely related to the graft site, indicating a direct transmission of CJD from the graft site to the adjacent brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181835     DOI: 10.1111/j.1440-1789.2007.00847.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Akira Takekoshi; Nobuaki Yoshikura; Takahiko Asano; Maya Mimuro; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takashi Inuzuka
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

3.  An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Nobuaki Yoshikura; Takahiko Asano; Maya Mimuro; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takashi Inuzuka
Journal:  Prion       Date:  2017-07-27       Impact factor: 3.931

4.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

5.  Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.

Authors:  Jacqueline Mikol; Jean-Philippe Deslys; Wen-Quan Zou; Wiangzhu Xiao; Paul Brown; Herbert Budka; Françoise Goutieres
Journal:  Clin Neuropathol       Date:  2012 May-Jun       Impact factor: 1.368

6.  System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Akio Akagi; Yuichi Riku; Hiroaki Miyahara; Atsushi Kobayashi; Tetsuyuki Kitamoto; Mari Yoshida
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.